FT516
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for FT516, covering 2023-04-03 to 2023-04-03. Get the full timeline:
Most recent: Clinical Trial Update: FT516 and IL2 With Enoblituzumab for Ovarian Cancer [Phase 1]